Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands

Bioorganic & Medicinal Chemistry
María L López-RodríguezJoaquín Del Río

Abstract

A series of new mixed benzimidazole-arylpiperazine derivatives were designed by incorporating in general structure III the pharmacophoric elements of 5-HT(1A) and 5-HT(3) receptors. Compounds 1-11 were synthesized and evaluated for binding affinity at both serotoninergic receptors, all of them exhibiting high 5-HT(3)R affinity (K(i)=10-62nM), and derivatives with an o-alkoxy group in the arylpiperazine ring showing nanomolar affinity for the 5-HT(1A)R (K(i)=18-150nM). Additionally, all the synthesized compounds were selective over alpha(1)-adrenergic and dopamine D(2) receptors (K(i)>1000-10,000nM). Compound 3 was selected for further pharmacological characterization due to its interesting binding profile as mixed 5-HT(1A)/5-HT(3) ligand with high affinity for both receptors (5-HT(1A): K(i)=18.0nM, 5-HT(3): K(i)=27.2nM). In vitro and in vivo findings suggest that this compound acts as a partial agonist at 5-HT(1A)Rs and as a 5-HT(3)R antagonist. This novel mixed 5-HT(1A)/5-HT(3) ligand was also effective in preventing the cognitive deficits induced by muscarinic receptor blockade in a passive avoidance learning test, suggesting a potential interest in the treatment of cognitive dysfunction.

References

Jul 4, 1989·European Journal of Pharmacology·D T WongL R Reid
Aug 24, 1984·Neuroscience Letters·E AmbrosioL M Orensanz
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·L Uphouse
Mar 10, 1998·Journal of Computer-aided Molecular Design·M L López-RodríguezM L Rosado
May 5, 1998·Neurochemical Research·F E Bloom, M Morales
May 7, 1998·European Journal of Pharmacology·R H Alper, D L Nelson
Jul 31, 1998·Journal of Medicinal Chemistry·J A BikkerC Humblet
Sep 24, 1998·Trends in Pharmacological Sciences·P R SaxenaC M Villalón
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Sep 7, 1999·Bioorganic & Medicinal Chemistry Letters·M L López-RodríguezM Murcia
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z SarnyaiM Toth
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Daniel HoyerGraeme R Martin
Apr 12, 2002·Current Medicinal Chemistry·M L López-RodríguezA Viso
Feb 4, 2003·The American Journal of Psychiatry·Fumihiko YasunoKazutoshi Suzuki
Feb 20, 2003·European Journal of Pharmacology·David PascualMaría Isabel Martín
Sep 3, 2003·Bioorganic & Medicinal Chemistry Letters·María L López-RodríguezJoaquín Del Río

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.